4-S-Cysteaminylphenol
Alternative Names: 4-S-CAPLatest Information Update: 22 Sep 1995
Price :
$50 *
At a glance
- Originator Tokyo Medical and Dental University
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 22 Sep 1995 No-Development-Reported for Cancer in Japan (Unknown route)